GB201207907D0 - Treatment of depression - Google Patents

Treatment of depression

Info

Publication number
GB201207907D0
GB201207907D0 GBGB1207907.5A GB201207907A GB201207907D0 GB 201207907 D0 GB201207907 D0 GB 201207907D0 GB 201207907 A GB201207907 A GB 201207907A GB 201207907 D0 GB201207907 D0 GB 201207907D0
Authority
GB
United Kingdom
Prior art keywords
depression
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1207907.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
E Therapeutics PLC
Original Assignee
E Therapeutics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Therapeutics PLC filed Critical E Therapeutics PLC
Priority to GBGB1207907.5A priority Critical patent/GB201207907D0/en
Publication of GB201207907D0 publication Critical patent/GB201207907D0/en
Priority to EP13730041.4A priority patent/EP2846786A1/en
Priority to JP2015509478A priority patent/JP2015515971A/ja
Priority to CA2871171A priority patent/CA2871171A1/en
Priority to AU2013255668A priority patent/AU2013255668A1/en
Priority to PCT/GB2013/000197 priority patent/WO2013164561A1/en
Priority to US14/398,201 priority patent/US20150093438A1/en
Priority to ZA2014/08849A priority patent/ZA201408849B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1207907.5A 2012-05-04 2012-05-04 Treatment of depression Ceased GB201207907D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB1207907.5A GB201207907D0 (en) 2012-05-04 2012-05-04 Treatment of depression
EP13730041.4A EP2846786A1 (en) 2012-05-04 2013-05-03 Tramadol for treating depression
JP2015509478A JP2015515971A (ja) 2012-05-04 2013-05-03 うつ病を治療するためのトラマドール
CA2871171A CA2871171A1 (en) 2012-05-04 2013-05-03 Tramadol for treating depression
AU2013255668A AU2013255668A1 (en) 2012-05-04 2013-05-03 Tramadol for treating depression
PCT/GB2013/000197 WO2013164561A1 (en) 2012-05-04 2013-05-03 Tramadol for treating depression
US14/398,201 US20150093438A1 (en) 2012-05-04 2013-05-03 Tramadol for Treating Depression
ZA2014/08849A ZA201408849B (en) 2012-05-04 2014-12-03 Tramadol for treating depression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1207907.5A GB201207907D0 (en) 2012-05-04 2012-05-04 Treatment of depression

Publications (1)

Publication Number Publication Date
GB201207907D0 true GB201207907D0 (en) 2012-06-20

Family

ID=46396577

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1207907.5A Ceased GB201207907D0 (en) 2012-05-04 2012-05-04 Treatment of depression

Country Status (8)

Country Link
US (1) US20150093438A1 (enExample)
EP (1) EP2846786A1 (enExample)
JP (1) JP2015515971A (enExample)
AU (1) AU2013255668A1 (enExample)
CA (1) CA2871171A1 (enExample)
GB (1) GB201207907D0 (enExample)
WO (1) WO2013164561A1 (enExample)
ZA (1) ZA201408849B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9980900B2 (en) 2015-12-22 2018-05-29 Revogenex Ireland Ltd Intravenous administration of tramadol
US9693949B1 (en) 2015-12-22 2017-07-04 Revogenex Ireland Ltd Intravenous administration of tramadol

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249109A (en) 1963-11-01 1966-05-03 Maeth Harry Topical dressing
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4144317A (en) 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4262003A (en) 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4307717A (en) 1977-11-07 1981-12-29 Lectec Corporation Sterile improved bandage containing a medicament
US4725439A (en) 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
AU3582101A (en) * 2000-03-01 2001-09-12 Euro-Celtique S.A. The treatment of functional gastrointestinal disorders
DE10015479A1 (de) 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
EP1905435A3 (en) * 2003-03-11 2008-05-14 Euro-Celtique S.A. Titration dosing regimen for controlled release tramadol
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
DE102006044694A1 (de) * 2006-09-22 2008-03-27 Krewel Meuselbach Gmbh Perorale feste Schmerzmittelzubereitung
GB0712101D0 (en) * 2007-06-22 2007-08-01 Therapeutics Ltd E Treatment of depression
GB0811024D0 (en) * 2008-06-17 2008-07-23 E Therapeutics Plc Sustained release treatment of depression
US20130296437A1 (en) * 2012-05-04 2013-11-07 E-Therapeutics Plc Treatment of Depression

Also Published As

Publication number Publication date
JP2015515971A (ja) 2015-06-04
CA2871171A1 (en) 2013-11-07
WO2013164561A1 (en) 2013-11-07
AU2013255668A1 (en) 2014-12-04
EP2846786A1 (en) 2015-03-18
ZA201408849B (en) 2015-12-23
US20150093438A1 (en) 2015-04-02

Similar Documents

Publication Publication Date Title
IL235593A0 (en) Bone marrow suppression treatment
SG11201405057YA (en) Treatment of biomass
ZA201406082B (en) Use of ccr3-inhibitors
GB201506561D0 (en) Treatment of amblyopia
GB201513279D0 (en) Micro-evolution of microbes
EP2903644A4 (en) TREATMENT OF CANCER
GB201501016D0 (en) Preparation of 18F-fluciclovine
GB201217892D0 (en) Treatment of cancer
GB201309274D0 (en) Treatment Of Fuel
SI2892925T1 (sl) Kombinacijsko zdravljenje raka
ZA201501038B (en) Treatment of wax
HUE036419T2 (hu) Légzõszervi depresszió kezelése
EP2804853A4 (en) THERAPEUTIC USES
GB201207907D0 (en) Treatment of depression
GB201217890D0 (en) Treatment of cancer
GB201221118D0 (en) Methods of treatment
GB201216740D0 (en) Methods of treatment
GB201216748D0 (en) Methods of treatment
GB201206325D0 (en) Methods of treatment
GB201206324D0 (en) Methods of treatment
GB201206326D0 (en) Methods of treatment
GB201206330D0 (en) Methods of treatment
GB201211135D0 (en) Treatment
GB201208690D0 (en) Treatment
GB201212604D0 (en) New treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)